In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.
Contains 13 relevant, practice-oriented topics including pharmacologic, non-pharmacologic, and device therapy for HFpEF; geriatric domains in patients with HFpEF; pulmonary hypertension in HFpEF; infiltrative, genetic, and other non-standard causes of HFpEF; echocardiography in HFpEF; and more.
Provides in-depth clinical reviews on heart failure with preserved ejection fraction, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction - p. 397 9. Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies - p. 415 10. Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction - p. 431 11. The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction - p. 443 12. Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction - p. 459 13. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction - p. 473 14. Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction - p. 491 15. Device Therapy for Heart Failure with Preserved Ejection Fraction - p. 507 16. Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction - p. 517 17. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction - p. 533 18. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an “Old” Disease - p. 541
In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.
Contains 13 relevant, practice-oriented topics including pharmacologic, non-pharmacologic, and device therapy for HFpEF; geriatric domains in patients with HFpEF; pulmonary hypertension in HFpEF; infiltrative, genetic, and other non-standard causes of HFpEF; echocardiography in HFpEF; and more.
Provides in-depth clinical reviews on heart failure with preserved ejection fraction, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction - p. 397 9. Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies - p. 415 10. Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction - p. 431 11. The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction - p. 443 12. Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction - p. 459 13. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction - p. 473 14. Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction - p. 491 15. Device Therapy for Heart Failure with Preserved Ejection Fraction - p. 507 16. Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction - p. 517 17. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction - p. 533 18. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an “Old” Disease - p. 541
